Newmarket, United Kingdom

Nicola Elisabeth Wilsher


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicola Elisabeth Wilsher: Innovator in Bicyclic Heterocycle Compounds

Introduction

Nicola Elisabeth Wilsher is a prominent inventor based in Newmarket, GB. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on bicyclic heterocycle compounds. Her research focuses on the therapeutic applications of these compounds, which hold promise in the treatment of various diseases, including cancer.

Latest Patents

Wilsher holds a patent for her invention titled "Bicyclic heterocycle compounds and their uses in therapy." This patent encompasses new bicyclic heterocycle compounds, pharmaceutical compositions that include these compounds, and their potential uses in treating diseases. The implications of her work are substantial, as it could lead to advancements in cancer treatment and other therapeutic areas.

Career Highlights

Throughout her career, Wilsher has been associated with Astex Therapeutics Limited, a company known for its focus on innovative drug discovery and development. Her role at Astex Therapeutics has allowed her to contribute to cutting-edge research and development in the pharmaceutical industry.

Collaborations

Wilsher has collaborated with notable colleagues, including Gianni Chessari and Christopher Norbert Johnson. These collaborations have further enhanced her research and development efforts, leading to impactful advancements in the field.

Conclusion

Nicola Elisabeth Wilsher is a trailblazer in the development of bicyclic heterocycle compounds, with her patent holding significant potential for therapeutic applications. Her work at Astex Therapeutics Limited and collaborations with esteemed colleagues underscore her contributions to the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…